LATEST ALERTS
Description
US president Joe Biden has called for a scheduling review of cannabis. Changing the schedule (rescheduling) or removing a controlled substance like cannabis completely from the schedules in the CSA (descheduling) can be done in two ways – by legislation or by administrative action. Legislation obviously requires Congress to pass a bill, but administrative action can be commenced at the request of certain agencies, like the Department of Health and Human Services (DHHS), as is the case here.
This report will examine the procedure, potential outcomes, and implications of this scheduling review.
Reasons to buy
A CannIntelligence regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Table of contents
- Executive summary
- Introduction
- Procedure for the review
- Scheduling criteria
- Scheduling criteria under the CSA
- Potential outcomes
- Effects of rescheduling cannabis
- Congress’s response to the review
Methodology
Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.
Latest reports
